Sun Pharma Advanced Research Company Ltd.

BSE: 532872 | NSE: SPARC |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE232I01014 | SECTOR: Biotechnology & Medical ResearchBiotechnology & Medical Research

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Sun Pharma Adv Sun Pharma Advanced Research Company Ltd. | BSE 134.85 0.40 (0.30%) | NSE 134.72 0.27 (0.20%) | Trade | Add

BSE Live

Dec 31, 12:19

134.85 0.40 (0.30%)

Volume

AVERAGE VOLUME

5-Day

194,347

10-Day

205,458

30-Day

1,073,476

13,939

Prev. Close

134.45
Open Price

133.80

Bid Price (Qty.)
134.65 (426)
Offer Price (Qty.)
134.90 (16)

NSE Live

Dec 31, 12:19

134.72 0.27 (0.20%)

Volume

AVERAGE VOLUME

5-Day

1,114,156

10-Day

1,449,563

30-Day

8,920,221

210,184

Prev. Close

134.45
Open Price

134.00

Bid Price (Qty.)
134.72 (64)
Offer Price (Qty.)
134.87 (72)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Sun Pharma Advanced Research Company (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
Per Share Ratios
Basic EPS (Rs.)	-11.92	-5.69	-7.94	-4.87	-2.96
Diluted EPS (Rs.)	-11.92	-5.69	-7.94	-4.87	-2.96
Cash EPS (Rs.)	-11.56	-5.49	-7.52	-4.49	-2.64
Book Value [ExclRevalReserve]/Share (Rs.)	-0.71	11.80	7.36	6.41	1.26
Book Value [InclRevalReserve]/Share (Rs.)	-0.71	11.80	7.36	6.41	1.26
Dividend / Share(Rs.)	0.00	0.00	0.00	0.00	0.00
Revenue from Operations/Share (Rs.)	2.93	7.29	3.12	7.33	6.81
PBDIT/Share (Rs.)	-11.46	-5.49	-9.47	-4.41	-2.55
PBIT/Share (Rs.)	-11.82	-5.79	-9.80	-4.75	-2.87
PBT/Share (Rs.)	-11.92	-5.80	-7.85	-4.82	-2.96
Net Profit/Share (Rs.)	-11.92	-5.80	-7.85	-4.82	-2.96
Profitability Ratios
PBDIT Margin (%)	-390.87	-75.34	-303.69	-60.20	-37.36
PBIT Margin (%)	-403.21	-79.47	-314.15	-64.75	-42.05
PBT Margin (%)	-406.69	-79.52	-251.72	-65.75	-43.39
Net Profit Margin (%)	-406.69	-79.52	-251.72	-65.75	-43.39
Return on Networth / Equity (%)	0.00	-49.09	-106.64	-75.26	-234.06
Return on Capital Employed (%)	-832.42	-47.89	-102.23	-72.35	-185.04
Return on Assets (%)	-114.61	-36.49	-63.79	-43.67	-43.02
Total Debt/Equity (X)	-3.64	0.00	0.01	0.02	1.85
Asset Turnover Ratio (%)	28.18	45.89	25.34	66.42	99.15
Liquidity Ratios
Current Ratio (X)	0.29	2.71	1.51	1.47	0.53
Quick Ratio (X)	0.29	2.71	1.51	1.47	0.53
Inventory Turnover Ratio (X)	0.00	0.00	0.00	0.00	0.00
Dividend Payout Ratio (NP) (%)	0.00	0.00	0.00	0.00	0.00
Dividend Payout Ratio (CP) (%)	0.00	0.00	0.00	0.00	0.00
Earnings Retention Ratio (%)	0.00	0.00	0.00	0.00	0.00
Cash Earnings Retention Ratio (%)	0.00	0.00	0.00	0.00	0.00
Valuation Ratios
Enterprise Value (Cr.)	2,596.18	4,818.56	9,494.88	7,751.74	6,858.14
EV/Net Operating Revenue (X)	33.80	26.35	121.33	42.82	42.52
EV/EBITDA (X)	-8.65	-34.97	-39.95	-71.13	-113.82
MarketCap/Net Operating Revenue (X)	32.92	26.35	121.32	43.20	42.26
Retention Ratios (%)	0.00	0.00	0.00	0.00	0.00
Price/BV (X)	-135.69	16.26	51.40	49.44	227.93
Price/Net Operating Revenue	32.92	26.35	121.32	43.20	42.26
Earnings Yield	-0.12	-0.03	-0.02	-0.02	-0.01